Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de John K. Clarke
Age : 66
Public asset : 64,356 USD
Linked companies : aTyr Pharma, Inc.
Summary 
John K. Clarke is an entrepreneur and businessperson who founded 8 companies, which include: Alnylam Pharmaceuticals, Inc., Cubist Pharmaceuticals LLC and Alkermes, Inc. and who has been at the head of 8 different companies. Currently, he holds the position of Chairman of aTyr Pharma, Inc. and Managing Partner at CHP Management, Inc. (which he founded in 2010). John K. Clarke is also on the board of Ivenix, Inc., Cureatr, Inc., Hands Together and Vividion Therapeutics, Inc.

Mr. Clarke previously was Independent Director at Alnylam Pharmaceuticals, Inc. (he founded the company in 2002), Chairman & President at Greater Philadelphia Venture Group, Chief Executive Officer of DNX Corp. (he founded the company), Chief Executive Officer of Arris Pharmaceuticals Corp. (he founded the company), Principal at General Electric Co., Chairman for Cubist Pharmaceuticals LLC (he founded the company in 1992), Chief Executive Officer for Alkermes, Inc. (he founded the company), Chief Executive Officer of Axys Pharmaceuticals, Inc., General Partner for DSV Partners IV LP and Director at Abide Therapeutics, Inc.

Mr. Clarke received an MBA from The Wharton School of the University of Pennsylvania and an undergraduate degree from Harvard University.


Current positions of John K. Clarke 
NameTitle Since
aTyr Pharma, Inc.
(Biotechnology & Medical Research)
Chairman 2005
CHP Management, Inc. Managing Partner 2011
Ivenix, Inc. Director -
Cureatr, Inc. Director -
Hands Together Trustee 2013
Vividion Therapeutics, Inc. Director 2014


Holdings of John K. Clarke 
NameEquities%Valuation
aTyr Pharma, Inc. (LIFE)
(Biotechnology & Medical Research)
7,4920.028%64,356 USD


John K. Clarke: Personal Network 
Most Read News 
11/23ELON MUSK : Tesla's Musk exercises more options, sells shares worth $1.05 billion
RE
11/24JAMIE DIMON : Jamie Dimon jokes that JPMorgan will outlast China's Communist Party
RE
11/17HENRIK FISKER : Fisker unveils electric SUVs to beat Tesla over driving range
RE
11/16ELON MUSK : Tesla's Musk sells another 934,000 shares to pay taxes after exercising options - filing
RE
11/16TED ROGERS : Rogers names Staffieri interim CEO as chair stamps authority after family feud
RE
11/26ELON MUSK : Tesla decides against state aid for German battery plant as Musk opposes subsidies
RE
11/15ELON MUSK : Tesla's Musk sells $930 mln in shares to cover stock option tax - filings
RE
11/23ERIK NORDSTROM : Nordstrom warns of supply shortages as holiday season approaches, shares plunge
RE
11/22MUKESH AMBANI : India's salesmen face ruin as tycoon Ambani targets mom-and-pop stores
RE
11/29ANIL AMBANI : India central bank to start bankruptcy procedure against Reliance Capital; co to comply
RE
More news


© 2021 People and Ownership :   
John K. Clarke : Connections